PRomoting Older Adults' Pneumococcal Vaccination Through Education and Learning

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

720 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-06

Study Completion Date

2024-12-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this trial is to compare the effect of a web-based educational video about pneumococcal vaccines and a reminder email to get vaccinated (intervention) with a reminder email alone (comparator) in adults aged 65 or older living in any Canadian province who reported not having received a pneumococcal vaccine.

The main questions this trial aims to answer are:

1. does the educational intervention improve pneumococcal vaccine uptake,
2. does the educational intervention improve willingness to be vaccinated,
3. does the educational intervention improve knowledge of pneumococcal vaccination,
4. and does the educational intervention improve attitudes towards pneumococcal vaccines/vaccination?

Eligible participants who provide electronic consent will:

1. fill out a web-based baseline survey,
2. receive access to the educational video (if assigned to the intervention group),
3. receive an email reminder to be vaccinated (both groups),
4. and fill in a web-based follow-up survey.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Reminder Emails to Improve Pneumococcal Vaccine Completion at 12 Months of Age

NCT06000397

Pneumococcal Vaccines Immunization Coverage

RECRUITING NA

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

NCT03835975

Pneumococcal Disease

COMPLETED PHASE3

Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults

NCT03760146

Pneumococcal Disease

COMPLETED PHASE3

Pneumonia Vaccine Education Intervention Study

NCT06136832

Pneumonia, Pneumococcal Vaccine

COMPLETED NA

A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older

NCT01646398

Pneumococcal Vaccines Pneumococcal Conjugate Vaccine

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This research project is a web-based randomized controlled trial (RCT), targeting adults aged 65 years and older across all Canadian provinces. The primary objectives of this study are twofold. Firstly, it aims to assess the participants' knowledge, barriers, facilitators, and willingness to receive the pneumococcal vaccine at baseline. Secondly, it aims to evaluate the impact of a video-led educational intervention on pneumococcal vaccine literacy, willingness to be vaccinated, and the actual uptake of the vaccine. To this end, participants will be recruited through various online channels. Only individuals who have not received the pneumococcal vaccine will be considered eligible for inclusion. For the second objective, participants will be randomly assigned to either the intervention group (short video on pneumococcal vaccination) or the control group (reminder to receive a pneumococcal vaccine). Consenting participants will be required to complete two surveys: one at baseline and another approximately six months post-intervention. These surveys will provide valuable data for analyzing the effectiveness of the educational intervention in improving participants' knowledge, willingness to be vaccinated, and the actual uptake of the pneumococcal vaccine. Findings from this research will contribute to the understanding of factors influencing pneumococcal vaccine decision-making among older adults, ultimately informing strategies to enhance vaccine uptake and public health outcomes in this population.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumococcal Vaccine Uptake Vaccination Willingness Pneumococcal Vaccine Knowledge Pneumococcal Vaccine Attitude

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants will be randomized 1:1 to receive either a web-based educational video about pneumococcal vaccination and a reminder email to be vaccinated or a reminder email alone.

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Web-based educational video on pneumococcal vaccination and reminder email to be vaccinated

Group Type ACTIVE_COMPARATOR

Web-based educational video on pneumococcal vaccination

Intervention Type OTHER

Participants will receive a link to view a short video on pneumococcal vaccination.

Reminder email to be vaccinated

Intervention Type OTHER

Participants will receive a reminder email to be vaccinated.

Reminder email to be vaccinated

Group Type PLACEBO_COMPARATOR

Reminder email to be vaccinated

Intervention Type OTHER

Participants will receive a reminder email to be vaccinated.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Web-based educational video on pneumococcal vaccination

Participants will receive a link to view a short video on pneumococcal vaccination.

Intervention Type OTHER

Reminder email to be vaccinated

Participants will receive a reminder email to be vaccinated.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. adults aged ≥ 65 residing in any Canadian province,
2. community dwelling (i.e., living outside of nursing homes),
3. reporting not having received a pneumococcal vaccine, and
4. being able to understand English and/or French.

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes